Literature DB >> 19327577

Diagnosis and treatment of acquired aplastic anemia.

Andrea Bacigalupo1, Jakob Passweg.   

Abstract

Acquired severe aplastic anemia can be treated successfully with either immunosuppressive therapy or bone marrow transplantation. Although immunosuppressive therapy can be readily administered to all patients, it is not a curative approach and is associated with a higher risk of clonal evolution than is transplantation, which yields rapid and long-lasting hematologic remission. This article reviews the key diagnostic and prognostic factors that influence the choice of therapy in patients with acquired aplastic anemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19327577     DOI: 10.1016/j.hoc.2009.01.005

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  6 in total

1.  Age-associated alteration of γδ T-cell repertoire and different profiles of activation-induced death of Vδ1 and Vδ2 T cells.

Authors:  Yoshihiro Michishita; Makoto Hirokawa; Yong-Mei Guo; Yukiko Abe; Jiajia Liu; Kumi Ubukawa; Naohito Fujishima; Masumi Fujishima; Tomoko Yoshioka; Yoshihiro Kameoka; Hirobumi Saito; Hiroyuki Tagawa; Naoto Takahashi; Kenichi Sawada
Journal:  Int J Hematol       Date:  2011-08-20       Impact factor: 2.490

2.  Effect of Tianshengyuan-1 (TSY-1) on telomerase activity and hematopoietic recovery - in vitro, ex vivo, and in vivo studies.

Authors:  Su Lu; Xiaotian Qin; Shaopeng Yuan; Yawei Li; Liming Wang; Yusheng Jin; Gang Zeng; Lawrence Yen; Jenny Hu; Tracie Dang; Sophie Song; Qi Hou; Jianyu Rao
Journal:  Int J Clin Exp Med       Date:  2014-03-15

3.  Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia.

Authors:  Amy E DeZern; Marianna Zahurak; Heather Symons; Kenneth Cooke; Richard J Jones; Robert A Brodsky
Journal:  Biol Blood Marrow Transplant       Date:  2016-12-21       Impact factor: 5.742

4.  Proliferation and apoptosis of bone marrow CD4(+) T cells in patients with aplastic anemia and impacts of the secreted cytokines on hematopoietic stem cells from umbilical cord blood.

Authors:  Miao Zheng; Hanying Sun; Jianfeng Zhou; Huizhen Xu; Lifang Huang; Wenli Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-02-14

5.  Should we still use Camitta's criteria for severe aplastic anemia?

Authors:  Hyun Hwa Yoon; Seok Jae Huh; Ji Hyun Lee; Suee Lee; Sung-Hyun Kim; Hyuk Chan Kwon; Hyo-Jin Kim
Journal:  Korean J Hematol       Date:  2012-06-26

6.  Evaluating and monitoring bone marrow hypoplasia in adults with aplastic anemia via high-resolution iliac magnetic resonance imaging in the current era.

Authors:  Xiawan Yang; Yanliang Bai; Huihui Guo; Mingyue Shi; Wanjun Zhang; Yanru Pei; Juanjuan Song; Emmanuel Kwateng Drokow; Gairong Huang; Xiang Liu; Junling Xu
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.